These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10215689)

  • 1. Characterization of the pharmacodynamic interaction between parent drug and active metabolite in vivo: midazolam and alpha-OH-midazolam.
    Tuk B; van Oostenbruggen MF; Herben VM; Mandema JW; Danhof M
    J Pharmacol Exp Ther; 1999 May; 289(2):1067-74. PubMed ID: 10215689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist: midazolam and flumazenil.
    Mandema JW; Tukker E; Danhof M
    J Pharmacol Exp Ther; 1992 Jan; 260(1):36-44. PubMed ID: 1309878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism-based modeling of the pharmacodynamic interaction of alphaxalone and midazolam in rats.
    Visser SA; Huntjens DR; van der Graaf PH; Peletier LA; Danhof M
    J Pharmacol Exp Ther; 2003 Nov; 307(2):765-75. PubMed ID: 12975494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo modeling of the pharmacodynamic interaction between benzodiazepines which differ in intrinsic efficacy.
    Mandema JW; Kuck MT; Danhof M
    J Pharmacol Exp Ther; 1992 Apr; 261(1):56-61. PubMed ID: 1560385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism-based pharmacodynamic modeling of the interaction of midazolam, bretazenil, and zolpidem with ethanol.
    Tuk B; van Gool T; Danhof M
    J Pharmacokinet Pharmacodyn; 2002 Jun; 29(3):235-50. PubMed ID: 12449497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of pharmacodynamic interactions between dexmedetomidine and midazolam in the rat.
    Bol CJ; Vogelaar JP; Tang JP; Mandema JW
    J Pharmacol Exp Ther; 2000 Jul; 294(1):347-55. PubMed ID: 10871332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers.
    Mandema JW; Tuk B; van Steveninck AL; Breimer DD; Cohen AF; Danhof M
    Clin Pharmacol Ther; 1992 Jun; 51(6):715-28. PubMed ID: 1611810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of arteriovenous concentration differences in pharmacokinetic-pharmacodynamic modeling of midazolam.
    Tuk B; Herben VM; Mandema JW; Danhof M
    J Pharmacol Exp Ther; 1998 Jan; 284(1):202-7. PubMed ID: 9435179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of change of blood concentrations is a major determinant of the pharmacodynamics of midazolam in rats.
    Cleton A; Mazee D; Voskuyl RA; Danhof M
    Br J Pharmacol; 1999 May; 127(1):227-35. PubMed ID: 10369477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 7-day exposure to midazolam on electroencephalogram pharmacodynamics in rats: a model to study multiple pharmacokinetic-pharmacodynamic relationships in individual animals.
    Laurijssens BE; Greenblatt DJ
    J Pharm Pharmacol; 2002 Jan; 54(1):77-86. PubMed ID: 11829133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive effect of midazolam and progesterone on the EEG in rats.
    Hoyo-Vadillo C; López-Trujillo E; Venturelli CR
    Proc West Pharmacol Soc; 2003; 46():132-3. PubMed ID: 14699909
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacodynamic interaction between midazolam and a low dose of ethanol in vivo.
    Hoyo-Vadillo C; Mandema JW; Danhof M
    Life Sci; 1995; 57(4):325-33. PubMed ID: 7603305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic interaction study between midazolam and the macrolide antibiotics, erythromycin, clarithromycin, and the azalide azithromycin.
    Yeates RA; Laufen H; Zimmermann T; Schumacher T
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):577-9. PubMed ID: 9455717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic-pharmacodynamic modelling of the EEG effects of midazolam in individual rats: influence of rate and route of administration.
    Mandema JW; Tukker E; Danhof M
    Br J Pharmacol; 1991 Mar; 102(3):663-8. PubMed ID: 1364836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated pharmacokinetics and pharmacodynamics of Ro 48-6791, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
    Dingemanse J; van Gerven JM; Schoemaker RC; Roncari G; Oberyé JJ; van Oostenbruggen MF; Massarella J; Segala P; Zell M; Cohen AF
    Br J Clin Pharmacol; 1997 Nov; 44(5):477-86. PubMed ID: 9384465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive changes in the pharmacodynamics of midazolam in different experimental models of epilepsy: kindling, cortical stimulation and genetic absence epilepsy.
    Cleton A; Voskuyl RA; Danhof M
    Br J Pharmacol; 1998 Oct; 125(4):615-20. PubMed ID: 9831893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro, pharmacokinetic, and pharmacodynamic interactions of ketoconazole and midazolam in the rat.
    Kotegawa T; Laurijssens BE; Von Moltke LL; Cotreau MM; Perloff MD; Venkatakrishnan K; Warrington JS; Granda BW; Harmatz JS; Greenblatt DJ
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1228-37. PubMed ID: 12183684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between midazolam and clarithromycin: comparison with azithromycin.
    Yeates RA; Laufen H; Zimmermann T
    Int J Clin Pharmacol Ther; 1996 Sep; 34(9):400-5. PubMed ID: 8880291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auditory and electroencephalographic effects of midazolam and alpha-hydroxy-midazolam in healthy subjects.
    Hotz MA; Ritz R; Linder L; Scollo-Lavizzari G; Haefeli WE
    Br J Clin Pharmacol; 2000 Jan; 49(1):72-9. PubMed ID: 10606840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism-based pharmacokinetic-pharmacodynamic modeling of concentration-dependent hysteresis and biphasic electroencephalogram effects of alphaxalone in rats.
    Visser SA; Smulders CJ; Reijers BP; Van der Graaf PH; Peletier LA; Danhof M
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1158-67. PubMed ID: 12183676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.